Search

Author/Creator Corazza, L.

2. OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study. (10th June 2014)

Authors:
Quartuccio, L.; Zuliani, F.; Corazza, L.; Scaini, P.; Zani, R.; Lenzi, M.; Tavoni, A.; Sebastiani, M.; Baldovino, S.; Urraro, T.; Saccardo, F.; Sbreglia, C.; Mazzaro, C.; Pioltelli, P.; Fraticelli, P.; Filippini, D.; Gabrielli, A.; Perrella, O.; Scarpato, S.; Roccatello, D.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins. (9th June 2015)

Authors:
Quartuccio, L.; Corazza, L.; Ramos-Casals, M.; Retamozo, S.; Ragab, G.M.; Ferraccioli, G.; Gremese, E.; Tzioufas, A.; Voulgarelis, M.; Vassilopoulos, D.; Koutsianas, C.; Scarpato, S.; Salvarani, C.; Guillevin, L.; Terrier, B.; Cacoub, P.; Saccardo, F.; Gabrielli, A.; Fraticelli, P.; Tomsic, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. SAT0175 Results of the Classification Criteria for Cryoglobulinemic Vasculitis Validation Study. (23rd January 2014)

Authors:
De Vita, S.; Quartuccio, L.; Isola, M.; Corazza, L.; Ramos-Casals, M.; Retamozo, S.; Ragab, G.; Zoheir, N.; El Menyawi, M. M.; Salem, M.; Sansonno, D.; Conteduca, V.; Ferraccioli, G.; Gremese, E.; Tzioufas, A.; Voulgarelis, M.; Vassilopoulos, D.; Koutsianas, C.; Zignego, A. L.; Urraro, T.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A640
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. SAT0205 Blys up-regulation and salivary clonal B-cell expansion characterize sjögren's syndrome-related lymphoproliferative disorders and correlate with the new ESSDAI score. (23rd January 2014)

Authors:
Quartuccio, L.; Salvin, S.; Fabris, M.; Maset, M.; Corazza, L.; Pontarini, E.; Isola, M.; De Vita, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
541
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study. (9th June 2015)

Authors:
Quartuccio, L.; Salvin, S.; Corazza, L.; Gandolfo, S.; Pistis, C.; Fabris, M.; De Vita, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
339
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy. (9th June 2015)

Authors:
Quartuccio, L.; De Marchi, G.; Rossi, F.; Zuliani, F.; Corazza, L.; Picco, L.; Masolini, P.; Rizzolio, F.; De Vita, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
342
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗